Agilent Technologies, Inc.
Agilent Technologies, Inc. is a global leader in life sciences and analytical instrumentation. It provides laboratories with tools and solutions for diagnostics, research, and testing.

Join Our Programs
Our clients trust us for our expert advice and in-depth market analysis. Discover our services to gain more knowledge on investing.
Stock Market Webinar
Join our Stock Market Webinar to gain clear, actionable insights into current market trends. Learn how to analyse data, interpret signals, and make informed investment decisions with confidence. Designed for both beginners and experienced investors, this session delivers practical knowledge you can apply immediately.

Performance
In fiscal year 2024, Agilent Technologies Inc. reported revenue of $6.51 billion, a 4.7% decline from the previous year, reflecting softness in some end markets. Despite the revenue dip, GAAP net income rose 6% to $1.29 billion, while non-GAAP earnings per share (EPS) slipped by 3% to $5.29. In the fourth quarter, the company posted $1.70 billion in revenue (up 0.8% year-over-year), with non-GAAP EPS increasing 6% to $1.46, though GAAP EPS fell 25% to $1.22. Looking ahead, Agilent forecasts fiscal 2025 revenue between $6.79 billion and $6.87 billion, and non-GAAP EPS in the range of $5.54 to $5.61, signaling a cautious but optimistic outlook.
Quality of Earnings
The company demonstrates strong adherence to General Accounting Principles, with financial reports that conform to GAAP, are decision-useful, sustainable, and offer returns exceeding the cost of capital. There have been no recent changes to accounting policies, and all required financial reports are submitted on time. Revenue quality is also robust, marked by high predictability—with a substantial portion of clients returning year after year—strong profitability with gross margins exceeding 70%, diversified income sources with no client accounting for more than 15% of revenue, and clear growth in both revenue and net income. Additionally, there are no significant financial report warning signs: earnings contain minimal accrual components, do not narrowly beat benchmarks in a suspicious pattern, and revenue is not recognized prematurely. Expenses are not misrepresented, audit opinions are unqualified, goodwill is properly assessed, and the company does not rely on aggressive accounting tactics such as related-party transactions or off-balance-sheet debt. Operating ccash flows align with net income, earnings are recurring and persistent, and there is no history of restatements or enforcement actions, reinforcing the reliability and quality of the company’s financial reporting.

Company Summary
Agilent Technologies, Inc. is a global leader in life sciences, diagnostics, and applied chemical markets, providing laboratories worldwide with advanced instruments, software, and services to enhance scientific research and ensure product quality.
